WeVote

Bill

Bill

A 2013

Requires non-invasive prenatal testing for pregnant persons and health insurance coverage for non-invasive prenatal testing.

2024-2025 Regular Session Introduced by Barbara McCann Stamato and 1 co-sponsor

New Jersey bill requiring health insurers to cover non-invasive prenatal testing for pregnant individuals to increase access to early genetic screening.

Introduced in the Assembly, Referred to Assembly Community Development and Women's Affairs Committee
0
WeVote Research Nonpartisan
Bill Summary · A 2013

Legislative bill overview

Bill A 2013 mandates that pregnant individuals have access to non-invasive prenatal testing (NIPT) and requires health insurance plans to cover these tests without cost-sharing. NIPT involves analyzing fetal DNA from maternal blood to screen for chromosomal abnormalities and genetic conditions, offering results earlier and with lower miscarriage risk than invasive procedures like amniocentesis.

Why is this important

Access to prenatal testing significantly impacts reproductive decision-making, allowing parents to prepare for potential health conditions or make informed choices about pregnancy continuation. Insurance coverage requirements remove financial barriers that may prevent some pregnant individuals from accessing these tests, potentially creating equity issues if coverage gaps exist. The bill reflects ongoing policy debates about reproductive autonomy, healthcare access, and which medical services should be universally covered.

Potential points of contention

  • Abortion concerns: Opponents may view mandatory coverage as implicitly promoting abortion access, while supporters argue it's about information access and reproductive choice
  • Scope of testing: Disagreement over which conditions warrant screening and whether broader genetic testing should be included beyond standard chromosomal abnormalities
  • Insurance cost implications: Insurers and employers may resist expanded coverage mandates citing premium increases, while advocates argue early detection reduces downstream healthcare costs
  • Informed consent standards: Questions about what counseling and education requirements should accompany testing to ensure truly informed decision-making

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.